top of page
All News
Thailand Registers Ravidasvir, a Simple-to-Use and Effective Antiviral for Hepatitis C, Expanding Treatment Options for Thai Patients
Thailand’s Food and Drug Administration (FDA) has approved ravidasvir as a safe and effective treatment against hepatitis C following clinical trials conducted in Thailand and Malaysia. Ravidasvir is approved for use in combination with another antiviral called sofosbuvir. The oral combination treatment is taken once daily for 12 weeks. The combination of ravidasvir and sofosbuvir—two direct-acting antivirals—was shown in clinical studies to be safe and effective, including i
Apr 283 min read
bottom of page